Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 15 of 144 pages ‹ First < 13 14 15 16 17 > Last ›
HSL15614
Chase, J
Alcon Labs uses brains to test ad effectiveness
Medical Marketing & Media 2009 Apr 144:(4):28
http://www.mmm-online.com/Alcon-Labs-uses-brains-to-test-ad-effectiveness/article/129850/
HSL15371
Alam K, Shah AK, Ojha P, Palaian S, Shankar PR.
Evaluation of drug promotional materials in a hospital setting in Nepal
Southern Med Review 2009 Apr; 2:(1):2-6
http://www.fmhs.auckland.ac.nz/sop/smr/_docs/SMR_Vol2_Issue1.pdf
HSL15461
PhRMA
Principles on Conduct of Clinical Trials: Communication of Clinical Trial Results
: PhRMA 2009 Apr
http://books.google.com.au/books?id=WijY8_miohQC&pg=PA132&lpg=PA132&dq=The+Pharmaceutical+Research+and+Manufacturers+of%0AAmerica+(PhRMA)+represents+research-based+pharmaceutical%0Aand+biotechnology+companies.+Our%0Amembers+discover,+develop,+manufacture+and+market+new%0Amedicines+and+vaccines+to+enable+patients+to+live+longer+and%0Ahealthier+lives.%0AThe+development+of+new+therapies+to+treat+disease+and%0Aimprove+quality+of+life+is+a+long+and+complex+process.+A+critical%0Apart+of+that+process+is+clinical+research,+the+study+of+a%0Apharmaceutical+product+in+humans+(research+participants).%0AClinical+research+involves+both+potential+benefits+and+risks+to%0Athe+participants+and+to+society+at+large.+Investigational+clinical%0Aresearch+is+conducted+to+answer+specific+questions,+and+some%0Aaspects+of+the+therapeutic+profile+(benefits+and+risks)+of+the%0Aproduct(s)+tested+cannot+be+fully+known+without+study+in%0Ahumans.+In+sponsoring+and+conducting+clinical+research,%0APhRMA+members+place+great+importance+on+respecting+and%0Aprotecting+the+safety+of+research+participants.%0APrinciples+for+the+conduct+of+clinical+research+are+set+forth+in%0Ainternationally+recognized+documents,+such+as+the+Declaration%0Aof+Helsinki+and+the+Guideline+for+Good+Clinical+Practice+of+the%0AInternational+Conference+on+Harmonization+(ICH).&source=bl&ots=_3NZSoatkl&sig=eV8SaUlyJOvHwDVWJVMGpHgss5w&hl=en&sa=X&ei=2KQTT42DIqaUiQe7r8DdCw&ved=0CCEQ6AEwAA#v=onepage&q=The%20Pharmaceutical%20Research%20and%20Manufacturers%20of%20America%20(PhRMA)%20represents%20research-based%20pharmaceutical%20and%20biotechnology%20companies.%20Our%20members%20discover%2C%20develop%2C%20manufacture%20and%20market%20new%20medicines%20and%20vaccines%20to%20enable%20patients%20to%20live%20longer%20and%20healthier%20lives.%20The%20development%20of%20new%20therapies%20to%20treat%20disease%20and%20improve%20quality%20of%20life%20is%20a%20long%20and%20complex%20process.%20A%20critical%20part%20of%20that%20process%20is%20clinical%20research%2C%20the%20study%20of%20a%20pharmaceutical%20product%20in%20humans%20(research%20participants).%20Clinical%20research%20involves%20both%20potential%20benefits%20and%20risks%20to%20the%20participants%20and%20to%20society%20at%20large.%20Investigational%20clinical%20research%20is%20conducted%20to%20answer%20specific%20questions%2C%20and%20some%20aspects%20of%20the%20therapeutic%20profile%20(benefits%20and%20risks)%20of%20the%20product(s)%20tested%20cannot%20be%20fully%20known%20without%20study%20in%20humans.%20In%20sponsoring%20and%20conducting%20clinical%20research%2C%20PhRMA%20members%20place%20great%20importance%20on%20respecting%20and%20protecting%20the%20safety%20of%20research%20participants.%20Principles%20for%20the%20conduct%20of%20clinical%20research%20are%20set%20forth%20in%20internationally%20recognized%20documents%2C%20such%20as%20the%20Declaration%20of%20Helsinki%20and%20the%20Guideline%20for%20Good%20Clinical%20Practice%20of%20the%20International%20Conference%20on%20Harmonization%20(ICH).&f=false
HSL15495
Impey D.
The blame game
PM Live 2009 Apr
http://www.pmlive.com/find_an_article/allarticles/categories/General/2009/april/features/the_blame_game
HSL15500
Lexchin J
Drug Safety and Health Canada: Going, Going…Gone?
: Canadian Centre for Policy Alternatives 2009 Apr
http://www.policyalternatives.ca/~ASSETS/DOCUMENT/National_Office_Pubs/2009/Drug_Safety_and_Health_Canada.pdf
HSL15526
Hirotsu M, Sohma M, Takagi H.
[Involvement of medical representatives in team medical care].
Gan To Kagaku Ryoho 2009 Apr; 36:(4):693-5
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=36040&seq=35
HSL15527
Hinsch K.
Bad Doc, Greedy Doc?
womensbioethicsproject 2009 Apr
http://www.womensbioethics.org/index.php?p=Do_You_Tip_Your_Docs_for_Botox&s=335
HSL15551
Institute of Medicine
Conflict of Interest in Medical Research, Education, and Practice: A Focus on Medical Research
: Institute of Medicine 2009 Apr
http://www.iom.edu/~/media/Files/Report%20Files/2009/Conflict-of-Interest-in-Medical-Research-Education-and-Practice/COI%20research%20report%20brief%20for%20web.pdf
HSL15605
Alkhateeb FM, Khanfar NM, Doucette WR, Loudon D.
Characteristics of Physicians Targeted by the Pharmaceutical Industry to Participate in E-detailing.
Health Mark Q. 2009 Apr; 26:(2):98-116
http://www.ncbi.nlm.nih.gov/pubmed/19408179
HSL15999
Rimonabant: marketing authorization suspended... at last: withdrawal. Half-measures.
Prescrire Int 2009 Apr; 18:(100):16
http://www.ncbi.nlm.nih.gov/pubmed/19585720
HSL16083
Martinez LS, Lewis N.
The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth.
J Health Commun. 2009 Apr-May; 14:(3):246-61
http://www.informaworld.com/smpp/content~db=all?content=10.1080/10810730902805820
HSL16084
Moliner J, Mozota J, MarÃa Abad J, Casaña L, Júdez D, José Rabanaque M
[Is it appropriate to research into physician-pharmaceutical industry relationships?]
Rev Calid Asist 2009 Apr; 24:(2):72-9
http://www.ncbi.nlm.nih.gov/pubmed/19426930
HSL16386
Kraepelin E, Freud S, Healy D.
Kraepelin-fraud syndrome.
Med Hypotheses 2009 Apr; 72:(4):378-80
Epub
http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(08)00662-2
HSL16664
Sismondo S.
Ghosts in the machine: publication planning in the medical sciences.
Soc Stud Sci 2009 Apr; 39:(2):171-98
http://www.ncbi.nlm.nih.gov/pubmed/19831220
HSL15362
Vioxx danger claim
Herald Sun 2009 Mar 31
http://www.news.com.au/heraldsun/story/0,21985,25266185-2862,00.html
HSL15374
Luchter L.
Prilosec OTC Firing Up BBQ At NASCAR
Marketing Daily 2009 Mar 31
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=103202
HSL15381
Cialis, Cymbalta Lead 2008’s Most Recalled Drug Ads
Pharma Live 2009 Mar 31
http://pharmalive.com/news/index.cfm?articleID=615946
HSL15384
Garattini S, Chalmers I.
Patients and the public deserve big changes in evaluation of drugs.
BMJ 2009 Mar 31; 338:b1025:
http://www.bmj.com/cgi/content/extract/338/mar31_3/b1025
HSL15385
Tremblay M.
Commentary: Risks of doing as the Romans do.
BMJ 2009 Mar 31; 338:b1107:
http://www.bmj.com/cgi/content/extract/338/mar31_3/b1107
HSL15392
Herper M.
A Doctor, Not A Nascar Driver
Forbes.com 2009 Mar 31
http://www.forbes.com/2009/03/31/acc-conference-pharmacuticals-advertising-business-healthcare-drug-ads.html
HSL15393
Tanne JH.
JAMA's new rule on whistleblowers creates controversy.
BMJ 2009 Mar 31; 338:b1352:
http://www.bmj.com/cgi/content/extract/338/mar31_2/b1352
HSL15351
Pharma events vital
Pharmacy Daily (Australia) - registration required 2009 Mar 30
http://www.pharmacydaily.com.au
HSL15360
Rout M.
Class action against drug begins today
The Australian 2009 Mar 30
http://www.theaustralian.news.com.au/story/0,25197,25260867-23289,00.html
HSL15361
Hagan K.
Firm denies drug cover-up
The Advertising Age 2009 Mar 30
http://www.theage.com.au/national/firm-denies-drug-coverup-20090329-9fkp.html
HSL15363
Mansell P.
IRB system flaws exposed at US Congressional hearing
Pharma Times 2009 Mar 30
http://www.pharmatimes.com/clinicalnews/article.aspx?id=15584
HSL15364
Federal Disclosure Would Help Editors Find Cheats
Integrity In Science 2009 Mar 30
http://www.cspinet.org/integrity/watch/index.html#1
HSL15367
Goldstein J.
AMA Wades Into Flap Over JAMA Editors
The Wall Street Journal Blog 2009 Mar 30
http://blogs.wsj.com/health/2009/03/30/ama-wades-into-flap-over-jama-editors/
HSL15380
Convey E.
Drug sales exec pleads guilty in Bextra case
Boston Business Journal 2009 Mar 30
http://boston.bizjournals.com/boston/stories/2009/03/30/daily25.html
HSL15337
Hundley K.
Approval process lowers the number of kids on atypical prescriptions.
St Petersburg Times 2009 Mar 29
http://www.tampabay.com/news/health/article987612.ece
HSL15365
Rust S, Fauber J.
Drug firms' cash skews doctor classes
JSOnline 2009 Mar 29
http://www.jsonline.com/news/42064977.html
HSL15369
Armstrong D.
Medical Group Seeks Probe of Its Journal
The Wall Street Journal 2009 Mar 28
http://online.wsj.com/article/SB123819137827260883.html
HSL15397
Cresswell A.
Drug companies censured over lavish doctors' seminars
The Australian 2009 Mar 28
http://www.theaustralian.news.com.au/story/0,25197,25253284-23289,00.html
HSL15336
Mashta O.
Banning drugs from NHS stifles new development, drug company says.
BMJ 2009 Mar 27; 338:b1295:
http://www.bmj.com/cgi/content/extract/338/mar27_2/b1295?papetoc
HSL15338
IMS, SDI Seek U.S. Supreme Court Review in Critical First Amendment Case
Pharma Live 2009 Mar 27
http://pharmalive.com/news/index.cfm?articleID=614990
HSL15339
Vedantam S.
Debate Over Drugs For ADHD Reignites
The Washington Post 2009 Mar 27
http://www.washingtonpost.com/wp-dyn/content/article/2009/03/26/AR2009032604018_pf.html
HSL15341
Luchter L.
Firm Faulted With Targeting Pharma Ads At Survey Respondents
Marketing Daily 2009 Mar 27
http://www.mediapost.com/publications/?fa=Articles.showArticle&art_aid=102947
HSL15342
Nonprofit Hits JAMA Editors, Urges Inquiry
The Wall Street Journal 2009 Mar 27
http://online.wsj.com/article/SB123810131860651487.html
HSL15359
Diller L.
Powerful proponent of psychiatric drugs for children primed for a fall
The San Francisco Chronicle 2009 Mar 27
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2009/03/27/EDAF16N963.DTL
HSL15366
Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
Pharma Live 2009 Mar 27
http://pharmalive.com/news/index.cfm?articleID=615034
HSL15373
Woodhead M.
More drug company dinners
6minutes (Australia) 2009 Mar 27
http://www.6minutes.com.au/dirplus/images/6minutes/newspluspharma/27_03_2009.pdf
HSL15383
Nathan VL.
UPDATE 1-Par Pharma gets subpoena on unit's promotional practice
Reuters 2009 Mar 27
http://www.reuters.com/article/rbssHealthcareNews/idUSBNG39708120090327
HSL15394
Gever J.
Little Policing to Guard Against Tainted Ivory Towers
MedPageToday 2009 Mar 27
http://www.medpagetoday.com/PublicHealthPolicy/Ethics/13454
HSL15395
Neale T.
GAO Sting Shows Independent Review Boards Are Vulnerable to Fraud
MedPage Today 2009 Mar 27
http://www.medpagetoday.com/PublicHealthPolicy/ClinicalTrials/13471
HSL15475
Reveler N.
Abolish DTCA ban, suggests CRTC boss
Media In Canada 2009 Mar 27
http://www.mediaincanada.com/articles/mic/20090327/crtc.html?__s=yes
HSL15333
Repeat form ads banned
Pharmacy Daily (Australia) - registration required 2009 Mar 26
http://www.pharmacydaily.com.au
HSL15335
Harris G.
Bill Would Let Copycats Compete With Biotech Drugs
The New York Times 2009 Mar 26
http://www.nytimes.com/2009/03/27/health/policy/27drug.html?ref=3Dus
HSL15348
Schachter SC, Mandell W, Harshbarger S, Grometstein R.
Managing Relationships with Industry: A Physician's Compliance Manual
The New England Journal of Medicine 2009 Mar 26; 360:(13):1366-1367
http://content.nejm.org/cgi/content/short/360/13/1366
HSL15368
CVS Caremark's Objectionable Drug Marketing Practices Raised at Massachusetts Joint Committee on Health Care Financing Hearing Today, According to CtW
Pharma Live 2009 Mar 26
http://pharmalive.com/news/index.cfm?articleID=614723
HSL15334
Clifford S.
Online Age Quiz Is a Window for Drug Makers
The New York Times 2009 Mar 25
http://www.nytimes.com/2009/03/26/technology/internet/26privacy.html?_r=4&hp
HSL15340
Mansell P.
GSK steps up commitment to research transparency
Pharma Times 2009 Mar 25
http://www.pharmatimes.com/clinicalnews/article.aspx?id=15559
HSL15344
The American Psychiatric Association Phases Out Industry-Supported Symposia
Pharma Live 2009 Mar 25
http://pharmalive.com/news/index.cfm?articleID=614455
HSL15345
Wang SS.
Psychiatrists to Stop Taking Meeting Money From Drug Makers
The Wall Street Journal Blog 2009 Mar 25
http://blogs.wsj.com/health/2009/03/25/psychiatrists-to-stop-taking-meeting-money-from-drug-makers/
HSL15346
Tanne JH.
US justice department sues company for off-label promotion of antidepressants for children.
BMJ 2009 Mar 25; 338:b1222:
http://www.bmj.com/cgi/content/extract/338/mar25_3/b1222?papetoc
HSL15347
Shaughnessy AF.
An insider’s view of the drug industry
BMJ 2009 Mar 25; 338:
http://www.bmj.com/cgi/content/extract/338/mar25_1/b1138?papetoc
HSL15353
Grogan K.
GSK puts 800 patents in 'pool', expands trials transparency
Pharma Times 2009 Mar 25
http://www.pharmatimes.com/WorldNews/article.aspx?id=15555&src=EWorldNews
HSL15396
Carey B.
Psychiatric Group Ends Industry-Sponsored Seminars
The New York Times 2009 Mar 25
http://www.nytimes.com/2009/03/26/health/26psych.html?_r=1
HSL15321
CH reform vital - Harvey
Pharmacy Daily (Australia) - registration required 2009 Mar 24
http://www.pharmacydaily.com.au
HSL15349
Boseley S.
Drug giants urged to create patent pools
The Guardian 2009 Mar 24
http://www.guardian.co.uk/society/2009/mar/24/pharamcuticals-patent-pools-hiv-drugs
HSL15352
Jack A.
GSK promises full drug trial disclosure
The Financial Times.com 2009 Mar 24
http://www.ft.com/cms/s/0/0976f2f2-18a7-11de-bec8-0000779fd2ac.html?nclick_check=1
HSL15354
Grogan K.
Merck & Co “targeted” by US government over Vioxx
Pharma Times 2009 Mar 24
http://www.pharmatimes.com/worldnews/article.aspx?id=15552
HSL15309
CHC - it ain’t broke
Pharmacy Daily (Australia) - registration required 2009 Mar 23
http://www.pharmacydaily.com.au
HSL15313
Armstrong D.
JAMA Sets New Policy in Wake of Disclosure Flap
The Wall Street Journal Health Blog 2009 Mar 23
http://blogs.wsj.com/health/2009/03/23/jama-sets-new-policy-in-wake-of-disclosure-flap/
HSL15356
O'Reilly KB.
Doctors increasingly close doors to drug reps, while pharma cuts ranks
American Medical News 2009 Mar 23
http://www.ama-assn.org/amednews/2009/03/23/prl10323.htm
HSL15358
Goldstein J.
The Long Decline of Drug Sales Reps
The Wall Street Journal Blog 2009 Mar 23
http://blogs.wsj.com/health/2009/03/23/the-long-decline-of-drug-sales-reps/
HSL15402
Day R, Komesaroff P, Mant A.
Do ethical Guidelines make a difference to decision making?
Internal Medicine Journal 2009 Mar 23;
http://www3.interscience.wiley.com/journal/122270203/abstract?CRETRY=1&SRETRY=0
HSL15507
Sadika Sultana M, Manivannan L.
Knowledge Management in Pharmaceutical Marketing: Theoretical Models
Social Science Research Network 2009 Mar 23; 7:(2):62-76
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1366930
HSL15357
Medical Journal Decries Public Airing of Conflicts
The Wall Street Journal 2009 Mar 22
http://online.wsj.com/article/SB123776823117709555.html#articleTabs%3Darticle
HSL15314
IMS World Pharmaceutical Market Summary March 2009
IMS Health 2009 Mar 21
http://www.imshealth.com/portal/site/imshealth/menuitem.a953aef4d73d1ecd88f611019418c22a/?vgnextoid=bb967900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default
HSL15329
Meilof JF, Hylkema MN.
The Lancet and advertorials.
Lancet. 2009 Mar 21; 373:(9668):1004
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(09)60600-0
HSL17453
Kowalczyk L
Senator broadens inquiry into psychiatrist
The Boston Globe 2009 Mar 21
http://www.boston.com/news/local/massachusetts/articles/2009/03/21/senator_broadens_inquiry_into_psychiatrist/
HSL15280
Bracey A.
Dubious complementary medicine ads set to face increased scrutiny
Medical Observer (Australia) 2009 Mar 20
http://www.medicalobserver.com.au/news/dubious-complementary-medicine-ads-set-to-face-increased-scrutiny
HSL15308
Roche WF.
UPMC to stop reps' delivery of drug samples
Pittsburgh Tribune-Review 2009 Mar 20
http://pittsburghlive.com/x/pittsburghtrib/news/cityregion/s_616956.html
HSL15312
DeAngelis CD, Fontanarosa PB.
Conflicts Over Conflicts of Interest
JAMA 2009 Mar 20; epub
http://jama.ama-assn.org/misc/jed90012pap_E1_E3.pdf
HSL15355
MHRA
Advertising complaint: Qvar (beclometasone dipropionate): Leavepiece
: MHRA 2009 Mar 20
http://www.mhra.gov.uk/Howweregulate/Medicines/Advertisingofmedicines/Advertisinginvestigations/CON041380
HSL15300
Olson J.
U doctor scrutinized over drug research
TwinCities.com 2009 Mar 19
http://www.twincities.com/ci_11945154
HSL15307
Harris G.
Drug Maker Told Studies Would Aid It, Papers Say
New York Times 2009 Mar 19
http://www.nytimes.com/2009/03/20/us/20psych.html
HSL15325
US drug sales growth continues slowdown in 2008
The Associated Press 2009 Mar 19
http://www.physorg.com/news156696781.html
HSL15331
Edwards J.
Pfizer District Sales Manager Guilty of Altering Off-Label Celebrex Documents
BNet 2009 Mar 19
http://industry.bnet.com/pharma/10001405/pfizer-district-sales-rep-found-guilty-of-altering-off-label-celebrex-documents/
HSL15376
Lerner M, Moore J.
Once-secret drug-company records put U on the spot
Star Tribune 2009 Mar 19
http://web.archive.org/web/20090324135131/http://www.startribune.com/lifestyle/health/41470522.html
HSL15281
Bud R.
Take this with a pinch of salt
BMJ 2009 Mar 18; 338:b1098
http://www.bmj.com/cgi/content/extract/338/mar18_1/b1098
HSL15285
Vedantam S.
A Silenced Drug Study Creates An Uproar
Washington Post 2009 Mar 18A01
http://www.washingtonpost.com/wp-dyn/content/article/2009/03/17/AR2009031703786.html
HSL15288
Koroneos G.
Fixing Pfizer's Rep: An Interview with Kathryn Metcalfe
PharmExec.com 2009 Mar 18
http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=587895
HSL15289
Wasserman T.
Excedrin's Latest Headache
Brandweek 2009 Mar 18
http://www.brandweek.com/bw/content_display/news-and-features/direct/e3ifaa96df164907e3427d83a16e0ac2e36
HSL15290
Burrow S.
Putting the pharma into pharmacy
Croakey, the Crikey health blog 2009 Mar 18
http://blogs.crikey.com.au/croakey/2009/03/18/putting-the-pharma-into-pharmacy-simon-burrow
HSL15291
Drug data fraud may spark marketing crackdown
New Scientist 2009 Mar 18
http://www.newscientist.com/article/mg20127003.500-drug-data-fraud-may-spark-marketing-crackdown.html
HSL15299
Carlson HJ.
Proposal would restrict drug marketing
Post-Bulletin (Rochester MN) 2009 Mar 18
http://news.postbulletin.com/newsmanager/templates/localnews_story.asp?z=16&a=390455
HSL15326
Koroneos G.
Pharma Media Spend Falls 18.4 Percent
PharmExec.com 2009 Mar 18
http://pharmexec.findpharma.com/pharmexec/Marketing/Pharma-Media-Spend-Falls-184-Percent/ArticleStandard/Article/detail/587891?contextCategoryId=43753
HSL15327
Taylor L.
EU Patent Court drug rulings 'must consider public interest'
Pharma Times 2009 Mar 18
http://www.pharmatimes.com/worldnews/article.aspx?id=15503
HSL15332
Masoni M, Guelfi MR, Gensini GF.
Google needs better control of its advertisements and suggested links
BMJ 2009 Mar 18; 338:
http://www.bmj.com/cgi/content/full/338/mar18_1/b1083
HSL15286
MacK J.
Botox v. Reloxin: Market Share Battle May Revive DTC Spending Late in 2009
Pharma Marketing Blog 2009 Mar 17
http://pharmamkting.blogspot.com/2009/03/botox-v-reloxin-market-share-battle-may.html
HSL15292
Gray S.
The internet marketing code
Pharmafocus 2009 Mar 17
http://www.pharmafocus.com/cda/focusH/1,2109,22-0-0-0-focus_feature_detail-0-492599,00.html
HSL15298
Ex-Pfizer Manager Found Guilty of Obstruction
PharmaLive 2009 Mar 17
http://pharmalive.com/news/index.cfm?articleID=613088
HSL15328
PBS Cuts Would Pose Threat To High-Value Jobs
Medicines Australia 2009 Mar 17
http://www.medicinesaustralia.com.au/pages/view_news.asp?id=124
HSL15256
Review of Information Resources for Complementary Medicines
Surry Hills, NSW: National Prescribing Service (Australia) 2009 Mar 16
http://www.nps.org.au/research_and_evaluation/research/current_research/complementary_medicines/review_of_info_resources
HSL15259
Edwards J.
Forest Labs' Lexapro Flap Over JAMA Article Will Likely Be Examined by the Feds
BNET 2009 Mar 16
http://industry.bnet.com/pharma/10001372/forest-labs-lexapro-flap-over-jama-article-will-likely-be-examined-by-the-feds/
HSL15317
Kollmorgen A.
More pressure on promotion
PharmainFocus 2009 Mar 16
http://www.pharmainfocus.com.au/
HSL15517
Van Der Weyden MB.
Doctors and the pharmaceutical industry: time for a national policy?
MJA 2009 Mar 15; 190:(8): 407-408
http://www.mja.com.au/public/issues/190_08_200409/van10295_fm.html
HSL15645
Arnold M.
DTC Report: Between Screens
Medical Marketing & Media 2009 Mar 15
http://www.mmm-online.com/DTC-Report-Between-Screens/article/129756
HSL15277
Russell MW.
Phentermine For Weight Loss - My Story
Self Help Blog 2009 Mar 14
http://www.drmartinrussell.com/phentermine-for-weight-loss-my-story/
HSL15297
Applbaum K.
Warning Label Spin: Further Reflections on What the FDA is Up Against
Somatosphere 2009 Mar 14
http://www.somatosphere.net/2009/03/warning-label-spin-further-reflections.html
Page 15 of 144 pages ‹ First < 13 14 15 16 17 > Last ›
